Drug Database
Back to search

Netherlands· NL-df959e12690d

Trasylol, oplossing voor infusie 10.000 KIE/ml

A aprotinin product containing aprotinine (rund), registered in Netherlands by Nordic Group B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC B02AB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTrasylol, oplossing voor infusie 10.0…ATCB02AB01REGISTER NO.NL-df959e12690dPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aprotinine (rund)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aprotinin is registered in 11 of 19 countries.

Countries holding a registration under ATC B02AB01 (aprotinin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search aprotinin products by name

Aprotinin · ATC B02AB01

11 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
APROTININE (RUND)
Manufacturer
Nordic Group B.V.
Country
Netherlands (NL)
ATC code
B02AB01
ATC class
Aprotinin
Defined daily dose
500 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    05312

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for aprotinin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aprotinin against other medicinesHow interaction checks work

Aprotinin · interactions on record

6 records

  • 3 severe
  • 3 moderate

Most severe, free to view

  • Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
  • TretinoinL01XF01severe
  • TretinoinL01XX14severe
  • AlteplaseB01AD02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aprotinin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aprotinin products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Trasylol
  • Belgium · Trasylol
  • Germany · Trasylol
  • Denmark · Trasylol
  • Finland · Trasylol
  • France · Trasylol
  • United Kingdom (Northern Ireland) · Aprotinin
  • Hungary · Gordox
  • Ireland · Trasylol
  • Luxembourg · Trasylol
  • Poland · Trasylol
  • Portugal · Trasylol
  • Sweden · Trasylol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/880e3900-ece9-49dd-969e-ddca873b9b0a
GET /v1/drugs/880e3900-ece9-49dd-969e-ddca873b9b0a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h05312_smpc.pdf",
  "strength": null,
  "atc_label": "Aprotinin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg05312",
  "excipients": [
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "APROTININE (RUND)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h05312.pdf",
  "authorised_at": "1968/10/09",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "05312",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about aprotinin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console